Manufacturing Services Agreement for ARX-01 December 12, 2012Manufacturing Services Agreement • May 1st, 2023 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
AMENDMENT #1 TO MANUFACTURING SERVICES AGREEMENT BETWEEN PATHEON PHARMACEUTICALS, INC. AND ACELRX PHARMACEUTICALS, INC.Manufacturing Services Agreement • May 1st, 2023 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations
WHEREAS Patheon Pharmaceuticals Inc. (“Patheon”) and AcelRx Pharmaceuticals, Inc. (“AcelRx”), have entered into a Manufacturing Services Agreement effective December 12, 2012 (the “Agreement”). Patheon and AcelRx are each a “Party” and are collectively the “Parties.”
AMENDED AND RESTATED CAPITAL EXPENDITURE AND EQUIPMENT AGREEMENTExpenditure and Equipment Agreement • May 1st, 2023 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations
THIS AMENDED AND RESTATED CAPITAL EXPENDITURE AND EQUIPMENT AGREEMENT (this “Agreement”) is made as of December 12, 2012 (the “Effective Date”) between
